Abstract

For HER2-positive esophagogastric adenocarcinoma, adding trastuzumab to first-line chemotherapy with a fluorinated pyrimidine and a platinum agent (FP)

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call